CD8A and neoplasm: This may be due to direct recognition of vaccine-derived antigen by the anergic CD8+ T cells, or indirectly due to the induction of antigen-specific CD4+ T cell help, which can also override tumor-induced peripheral tolerance and trigger tumor control (185, 186, 189).